Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
- 1Department of Pharmacy, University of Salerno, Fisciano, Italy
- 2Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States
- 3H. L. Moffitt Comprehensive Cancer Center, Tampa, FL, United States
- 4New England Inflammation and Tissue Protection Institute, Northeastern University, Boston, MA, United States
- 5Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, United States
A Corrigendum on
Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
by Sorrentino, C., Hossain, F., Rodriguez, P. C., Sierra, R. A., Pannuti, A., Hatfield, S., et al. (2019). Front. Immunol. 10:162. doi: 10.3389/fimmu.2019.00162
“Stephen Hatfield” was not included as an author in the published article. The corrected Author Contributions Statement appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Author Contributions
SM and LM conceived the study, supervised experiments, and prepared the final version of the manuscript. CS, FH, AP, and RS performed experiments and interpreted their results. PR supervised experiments in Notch1IC-transgenic T-cells, which were performed by RS. SH provided A2AR−/− T cells and was responsible for maintaining adenosine receptor transgenic mouse lines. BO and LMM provided expertise on TCR signaling and PKC activity, contributed to result interpretation, reviewed and edited the final version of the manuscript.
Keywords: adenosine, A2A adenosine receptor (A2AR), Notch1, CD8+T-cells, immunosuppression
Citation: Sorrentino C, Hossain F, Rodriguez PC, Sierra RA, Pannuti A, Hatfield S, Osborne BA, Minter LM, Miele L and Morello S (2019) Corrigendum: Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells. Front. Immunol. 10:935. doi: 10.3389/fimmu.2019.00935
Received: 12 March 2019; Accepted: 11 April 2019;
Published: 03 May 2019.
Approved by:
Frontiers in Immunology Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2019 Sorrentino, Hossain, Rodriguez, Sierra, Pannuti, Hatfield, Osborne, Minter, Miele and Morello. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lucio Miele, bG1pZWxlQGxzdWhzYy5lZHU=
Silvana Morello, c21vcmVsbG9AdW5pc2EuaXQ=